Search PubMed⌕ Search

Biomedical subjects

E B Feldman

Publications and source records attributed to E B Feldman.

At least 73 records · Page 4Linked to original sources

Mucosal uptake in vitro of cholesterol from bile salt and surfactant solutions.

That bile salts are required for intestinal absorption of cholesterol is well known, but the mechanism of action is elusive. Substitution of other surfactant micelles and inclusion of fatty acid or monoglyceride variably influenced sterol transport. In this study, rat jejunal mucosal sheets were exposed for 1-2 min to 10 mM micellar solutions of taurodeoxycholate, dodecylsulfate, Tween 80 or cetyltrimethylammonium bromide containing cholesterol, 0.25 mM. Monoolein and/or oleic acid were variably added. Cholesterol influx was insignificant in all solubilizers without additives. With taurodeoxycholate, addition of monoolein progressively enhanced influx from 13 nmoles/cm-2 per hour to 29 nmoles/cm-2 per hour (0.67-5.4 mM monoglyceride). Oleic acid, 3 mM, was as effective as 5.4 mM monoolein. Oleic acid, 3 mM, added to monoolein 3 mM maximized influx (42 nmoles/cm-2 per hour). With cetyltrimethylammonium bromide, monoolein 0.67 mM enhanced influx to 13 nmoles/cm-2 per hour but further additions of monoolein with or without oleic acid had no added effect. Additives had no material effect on the insignificant influx from the other anionic or nonionic surfactants. These results are not explained by differences in cholesterol, monoolein or oleic acid partition or in micellar sizes. Specific interactions of bile salt and fatty acid or monoglyceride with the plasma membrane are postulated in cholesterol absorption.

Animals↗

Metabolic parameters in women with metastatic breast cancer.

The metabolic mechanism for increased circulating free fatty acids in post-menopausal women with metastatic breast cancer was investigated. Hormone and metabolic response to glucose and growth hormone were compared to cancer patients and control subjects; thyroid, adrenal and pituitary function were evaluated. The results of these studies indicated that breast cancer patients had glucose intolerance and delayed and prolonged insulin secretion, increased basal growth hormone levels and insensitivity of adipose tissue to growth hormone. Cortisol and protein-bound iodine levels were normal and there was no lipolytic factor in the sera of breast cancer patients. The changes observed in breast cancer patients were not attributable to age, obesity, inanition or stress. These metabolic abnormalities may characterize host susceptibility to breast cancer or be effects of tumor.

Adipose Tissue↗

Effects of halofenate on glucose tolerance in patients with hyperlipoproteinemia.

Halofenate, a triglyceride- and uric acid-lowering drug, potentiated the effect of oral hypoglycemics. Its effect on serial glucose tolerance was evaluated in ten patients with hypertriglyceridemia without overt diabetes. Six-hour oral glucose tolerance tests were done during a control period and every 24 weeks over two years of halofenate treatment. Abnormal glucose tolerance (chemical diabetes) was observed during the control period in six of ten patients. The number of abnormal tests gradually decreased to none by 48 weeks. Plasma glucose, insulin, and free fatty acid values during the glucose tolerance tests were reduced significantly. Halofenate induced significant serum uric acid reduction. No significant regressions were observed among levels of lipids, hormones, glucose, and uric acid. The mechanisms by which lipid-lowering drugs improve glucose tolerance are as yet unexplained.

Adult↗